Cargando…
Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure –1 year results from the Ce mark trial
BACKGROUND: The HeartMate 3 Left Ventricular Assist System (LVAS) (St. Jude Medical Inc., St Paul, MN) with full magnetic levitation allows for wide and consistent blood flow paths and an artificial pulse designed for enhanced hemocompatibility. The HeartMate 3 received market approval in the Europe...
Autores principales: | Krabatsch, Thomas, Netuka, Ivan, Schmitto, Jan D., Zimpfer, Daniel, Garbade, Jens, Rao, Vivek, Morshuis, Michiel, Beyersdorf, Friedhelm, Marasco, Silvana, Damme, Laura, Pya, Yuriy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379553/ https://www.ncbi.nlm.nih.gov/pubmed/28376837 http://dx.doi.org/10.1186/s13019-017-0587-3 |
Ejemplares similares
-
Twisting and constriction of a HeartMate II driveline in the area of a repair site
por: Maier, Sven, et al.
Publicado: (2020) -
Correction to: Twisting and constriction of a HeartMate II driveline in the area of a repair site
por: Maier, Sven, et al.
Publicado: (2021) -
Influence of a fully magnetically levitated left ventricular assist device on functional interrogation of implantable cardioverter defibrillators
por: Schukro, Christoph, et al.
Publicado: (2019) -
Infectious complications in patients with ventricular assist device HeartMate II
por: Konarik, M, et al.
Publicado: (2013) -
Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
por: Numan, Lieke, et al.
Publicado: (2023)